Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BBIBP-CorV immunogenicity in adults in Guinea
NCT05409300Phase 2Active, not recruiting
- Sponsor
- ANRS
- Start
- Apr 2022
- Primary completion
- Aug 2023
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of BBIBP-CorV in coronavirus disease 2019 (COVID-19), sponsored by ANRS. Started Apr 2022; status: active, not recruiting.
02
Drugs
BBIBP-CorV
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05409300.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05409300.